Health Care/Hospital

Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research

New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development.  FREMONT, Calif., Oct. 10, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the...

2025-10-10 05:23 1349

Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery

NORWALK, Conn., Oct. 9, 2025 /PRNewswire/ -- Lifespan Vision Ventures congratulates its portfolio company, Algen Biotechnologies, on the announcement of its multi-target research collaboration with AstraZeneca to advance AI-powered drug discovery in immunology. The partnership will combine Algen...

2025-10-09 23:09 1165

Kimberly-Clark Launches Enhanced Global Partnerships to Advance Essential Care for 24 Million Women and Girls

DALLAS, Oct. 9, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) is deepening its commitment to advancing essential care for women and girls ...

2025-10-09 21:05 1784

LuX-Valve Plus Approved for Hong Kong-Macao Medicine and Equipment Connect

BEIJING, Oct. 9, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with comprehensive structural heart disease interventional solutions, recently announced that LuX-Valve Plus transjugular tricuspid valve replacemen...

2025-10-09 21:00 1343

Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission

* The phase 3 clinical trial of HANSIZHUANG for perioperative gastric cancer treatment met its EFS primary endpoint, supporting an early New Drug Application (NDA) submission * World-first regimen in gastric cancer that replaces adjuvant chemotherapy with mono-immunotherapy in the perioperati...

2025-10-09 20:50 1596

Field Medical First-in-Human 6-Month Data Selected for Late-Breaking Clinical Trial at VT Symposium 2025

Three sessions feature new outcomes, a live case, and preclinical research with the FieldForce™ Ablation System. CARDIFF-BY-THE-SEA, Calif., and PHILADELPHIA, Oct. 9, 2025 /PRNewswire/ --  Field Medical, Inc

2025-10-09 20:33 1114

Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87

HANGZHOU, China, Oct. 9, 2025 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced that it has reached an exclusive commercialization agreement wit...

2025-10-09 17:27 1319

Herbalgy, the Pain Management Expert, Partners with Heroes in White to Champion a "Pain-Relieving Serenity" Lifestyle

Bringing the Wisdom of Traditional Chinese Medicine into Modern Living HONG KONG, Oct. 9, 2025 /PRNewswire/ -- Following the phenomenal success of TVB's widely acclaimed TV dramaHeroes in White—the top-rated series of 2025 with an audience of over 1.57 million and a rating of 24.2 points—Herbalgy...

2025-10-09 14:18 1144

Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology

* The published study results are from the ENLIGHT UC study (ES101002), a multicenter, randomized, double-blind and placebo-controlled Phase III trial of etrasimod conducted acrossAsia. The study included a 12-week induction phase followed by a 40-week maintenance phase and represents the large...

2025-10-09 13:10 1310

Breakthrough Lectures to Headline the 2025 World Congress of Neurology in Seoul

SEOUL, South Korea, Oct. 9, 2025 /PRNewswire/ -- The World Federation of Neurology (WFN) and the Korean Neurological Association (KNA) will host the XXVII World Congress of Neurology

2025-10-09 04:41 1107

India's No: 1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic 'Switches' that can transform Disease Research

CHENNAI, India, Oct. 8, 2025 /PRNewswire/ -- India's No:1 Ranked Institute, the Indian Institute of Technology Madras , and Danish researchers have shown how interactions between genetic variants can act like 'switches' to unlock hidden cellular pathways.

2025-10-08 21:48 1244

NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street

NEW YORK, Oct. 8, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + The AW Playmaker Award...

2025-10-08 21:20 1927

Public Interest Registry Unveils Winners of 7th Annual .ORG Impact Awards at DC Ceremony Hosted by Grammy-Award Winning Artist Common

The Fund for Congolese Women named 2025 .ORG of the Year, selected from nearly 3,000 applicants from more than 120 countries WASHINGTON, Oct. 8, 2025 /PRNewswire/ -- Public Interest Registry

2025-10-08 21:00 949

/C O R R E C T I O N -- World Meditation League (WML)/

In the news release, An Era Where Meditation Becomes a Quantifiable Achievement --Japan's First "Quantified Meditation Challenge", issued Oct. 7, 2025 by World Meditation League (WML) over PR Newswire, we are advised by the company that the photos have been updated. The complete, corrected releas...

2025-10-08 19:46 2578

AXA BetterMe Weekend Celebrates Fifth Anniversary

Championing holistic well-being and sustainable living Building for a healthier future HONG KONG, Oct. 8, 2025 /PRNewswire/ -- AXA Hong Kong and Macau (AXA) is excited to announce the return of its annual community event, theAXA BetterMe Weekend. Now in its fifth year, the carnival underscores AX...

2025-10-08 17:10 1369

BTL Files Patent Infringement Lawsuit Against WonderFace Device

PRAGUE, Oct. 8, 2025 /PRNewswire/ -- BTL Group, a global leader in medical solutions, today announced that it has initiated an international patent infringement action before the Unified Patent Court against Lexter Microelectronic Engineering Systems S.L., the manufacturer of the WonderFace devi...

2025-10-08 16:14 1409

Siemens Healthineers and National University Hospital Partner on Research to Advance Non-Invasive Liver Disease Diagnostics

* Partnership will evaluate advanced ultrasound technologies to improve early detection and monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease * Advancing ultrasound technologies that are safer, more accessible alternatives to invasive diagnostic procedures * Research le...

2025-10-08 11:15 1487

New White Paper by APAC CVD Alliance and Deloitte Charts Path to Tackle Rising Heart Failure Burden in Asia-Pacific

* 32 million people in Asia-Pacific live with heart failure, and this number is rising fast. * New blueprint targets a 20% cut in hospitalisations and 15% boost in survival rates within 5 years. * Urgent call for early diagnosis, digital and community-based care, and sustainable financing t...

2025-10-08 09:00 1623

New Global Beauty & Wellbeing Report unveils Emotional Wellbeing as the True Face of Beauty

New proprietary research from Oriflame redefines beauty as a powerful driver of wellbeing STOCKHOLM, Oct. 8, 2025 /PRNewswire/ -- Global beauty and wellbeing company, Oriflame, today releases its firstBeauty & Wellbeing Report, revealing a major shift in how women around the world experience and...

2025-10-08 07:01 1375

Global Direct Selling Leader QNET Celebrates 27 Years, Showcasing Economic Impact and Announces Landmark Ghana Convention

PENANG, Malaysia, Oct. 8, 2025 /PRNewswire/ -- QNET, a leading global lifestyle and wellness direct selling company, concluded its spectacular 27th-anniversary convention,V-Malaysia 2025

2025-10-08 06:06 1868
1 ... 26272829303132 ... 550